University Of Texas Beam Therapeutics Inc. Transaction History

University Of Texas

  • $590 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 22, 2023
BUY
$30.15 - $48.79 $1.8 Million - $2.92 Million
59,839 New
59,839 $1.83 Million
Q3 2021

Nov 09, 2021
SELL
$84.37 - $133.6 $18.9 Million - $30 Million
-224,391 Closed
0 $0
Q2 2021

Aug 06, 2021
BUY
$64.12 - $128.71 $64 - $128
1 Added 0.0%
224,391 $28.9 Million
Q1 2021

May 07, 2021
BUY
$71.28 - $120.75 $16 Million - $27.1 Million
224,390 New
224,390 $18 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track University Of Texas Portfolio

Follow University Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on University Of Texas with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email